Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0615-8007

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0615-8007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Atorvastatin Tabs Apotex 8007 8009 1)

Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including calcium ions and associated components.*

FDA Label Image

Figure-01 (Atorvastatin Tabs Apotex 8007 8009 2)

A line graph depicting cumulative incidence percentage over time in years, comparing Atorvastatin versus Placebo. The graph shows a lower cumulative incidence for Atorvastatin compared to Placebo, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005, indicating statistical analysis results.*

FDA Label Image

Figure-02 (Atorvastatin Tabs Apotex 8007 8009 3)

A line graph depicting cumulative hazard percentages over time for Atorvastatin versus placebo. The x-axis represents years to the first primary endpoint over four years of follow-up, and the y-axis represents cumulative hazard percentage. The graph shows a lower cumulative hazard for Atorvastatin compared to placebo, with corresponding hazard ratio and p-value.*

FDA Label Image

Figure-03 (Atorvastatin Tabs Apotex 8007 8009 4)

A line chart comparing Atorvastatin 10 mg and 80 mg showing the percentage of subjects experiencing events over a 5-year time to first major cardiovascular endpoint. The graph includes hazard ratio and p-value statistics, illustrating event rates for each dose over time.*

FDA Label Image

Principal Display Panel (Atorvastatin Tabs Apotex 8007 8009 5)

This image shows a packaging label for Atorvastatin Calcium Tablets USP, 20 mg, manufactured by Apotex and packaged by Vangard Labs in Glasgow, KY. The label indicates a quantity of 30 tablets, includes multiple barcodes, lot number 8007, and storage instructions. It states the product is for institutional use only and contains atorvastatin equivalent to 22 mg atorvastatin calcium.*

FDA Label Image

Principal Display Panel (Atorvastatin Tabs Apotex 8007 8009 6)

Atorvastatin Calcium tablet labels from Vangard Labs, Glasgow, KY, displaying 20 mg strength of the film-coated tablets. The label includes the drug name, dosage, manufacturer information, lot number, and barcodes. The packaging details include quantity as 30 tablets and storage conditions, with reference to the USP controlled room temperature guidelines.*

FDA Label Image

Principal Display Panel (Atorvastatin Tabs Apotex 8007 8009 7)

Label for Atorvastatin Calcium tablets USP 80 mg, film-coated oral tablets. The label includes multiple barcodes, lot number 8009, and manufacturer information for Apotex and packaging by Vanguard Labs in Glasgow, KY. It indicates a quantity of 30 tablets per package and storage instructions. Marked for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.